CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Biotech
Original article

NYSE Content Update: AdvanCell Raises $315 Million to Fight Prostate Cancer

Positive
AI Analysis

Summary

AdvanCell raised $315 million in funding to support its prostate cancer treatment efforts. The financing was announced via NYSE pre-market advisory on July 17, 2026.

Importance:5/10
Sentiment:
0.60
financingoncologyprostate cancercapital raise

Read the original article

Published by PR Newswire Biotech on July 17, 2026 12:55 PM

Read Original